Dai Hashimoto Selected Research

Disease Progression

1/2021	Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
1/2015	Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dai Hashimoto Research Topics

Disease

10	Idiopathic Pulmonary Fibrosis 01/2021 - 08/2010
9	Asthma (Bronchial Asthma) 01/2019 - 04/2012
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2004
7	Infections 10/2021 - 01/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 01/2020
4	Neoplasms (Cancer) 01/2022 - 06/2012
4	Idiopathic Interstitial Pneumonias 03/2021 - 05/2008
4	Inflammation (Inflammations) 01/2015 - 04/2012
3	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
3	Vascular Diseases (Vascular Disease) 03/2021 - 06/2009
2	Hypersensitivity (Allergy) 03/2021 - 01/2021
2	Pneumonia (Pneumonitis) 03/2021 - 01/2021
2	Pneumothorax 01/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 12/2008
2	Fibrosis (Cirrhosis) 01/2016 - 08/2010
2	Sarcoidosis (Schaumann Disease) 01/2015 - 01/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015 - 10/2009
2	Airway Obstruction (Choking) 09/2014 - 04/2013
2	Tuberculosis (Tuberculoses) 09/2008 - 04/2008
1	Lung Diseases (Lung Disease) 06/2022
1	Invasive Pulmonary Aspergillosis 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Nontuberculous Mycobacterium Infections 10/2021
1	Proteinuria 01/2021
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Autoimmune Pancreatitis 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Carrington syndrome 06/2015
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 06/2015
1	Airway Remodeling 09/2014
1	Bronchiectasis 01/2014
1	Necrosis 06/2012

Drug/Important Bio-Agent (IBA)

10	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 04/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 04/2012
4	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2010
4	CollagenIBA 03/2021 - 06/2009
4	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 06/2012
4	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
4	VaccinesIBA 11/2015 - 04/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	ErbB Receptors (EGF Receptor)IBA 06/2022 - 01/2021
2	NivolumabIBA 01/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2005
2	LigandsIBA 01/2020 - 06/2012
2	pirfenidoneIBA 11/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 11/2019 - 11/2004
2	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	Prednisolone (Predate)FDA LinkGeneric 06/2015 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 01/2015 - 01/2014
2	Connective Tissue Growth FactorIBA 09/2014 - 11/2011
2	Salmeterol Xinafoate (Serevent)FDA Link 02/2014 - 06/2012
2	Fluticasone (Cutivate)FDA LinkGeneric 02/2014 - 06/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014 - 11/2004
2	EpitopesIBA 11/2011 - 10/2009
2	Therapeutic UsesIBA 01/2011 - 05/2008
1	atezolizumabIBA 07/2022
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Voriconazole (Vfend)FDA LinkGeneric 06/2022
1	CholesterolIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	AutoantibodiesIBA 10/2021
1	Interferon-gamma (Interferon, gamma)IBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2020
1	fluticasone furoate FDA Link 01/2019
1	AntiemeticsIBA 01/2019
1	vilanterolIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018
1	LectinsIBA 01/2016
1	wisteria lectinIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	VitronectinIBA 11/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2014
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2014
1	Hematoxylin (Haematoxylon)IBA 05/2014
1	CytokinesIBA 01/2014
1	Methotrexate (Mexate)FDA LinkGeneric 09/2013
1	B-Cell Activating FactorIBA 06/2012
1	Retinaldehyde (Retinal)IBA 06/2012

Therapy/Procedure

12	Therapeutics 07/2022 - 06/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Hemoperfusion 02/2015 - 01/2011
2	Nebulizers and Vaporizers (Inhaler) 02/2014 - 06/2012
1	Immunotherapy 01/2020
1	Dry Powder Inhalers 01/2019
1	Length of Stay 11/2016
1	Aftercare (After-Treatment) 06/2015
1	Traction 01/2014